Tag Archives: British

Director General Balram Bhargava of the Indian Council of Medical Research (ICMR) has announced that Phase 2 clinical trials of two indigenously developed COVID-19 vaccines have been almost completed. India has two indigenous vaccine candidates—ZyCOV-D by Zydus Cadila and Covaxin by Bharat Biotech. He said that while final trials normally …

According to Japanese health minister Katsunobu Kato, British company AstraZeneca Plc will supply 120 million doses of its vaccine being developed with the University of Oxford. The first tranche of 30 million doses will be received in March, 2021. AstraZeneca is conducting the final-stage clinical trial of its experimental AZD1222 …